Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1993 1
1997 1
1998 1
2000 1
2001 2
2002 1
2003 1
2005 2
2007 2
2010 2
2011 1
2012 2
2013 3
2015 3
2016 4
2018 2
2019 3
2021 3
2022 3
2023 3
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for gabriel mucin
Search for Gabriel Muciño instead (2 results)
Congestion in heart failure: a circulating biomarker-based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology.
Núñez J, de la Espriella R, Rossignol P, Voors AA, Mullens W, Metra M, Chioncel O, Januzzi JL, Mueller C, Richards AM, de Boer RA, Thum T, Arfsten H, González A, Abdelhamid M, Adamopoulos S, Anker SD, Gal TB, Biegus J, Cohen-Solal A, Böhm M, Emdin M, Jankowska EA, Gustafsson F, Hill L, Jaarsma T, Jhund PS, Lopatin Y, Lund LH, Milicic D, Moura B, Piepoli MF, Ponikowski P, Rakisheva A, Ristic A, Savarese G, Tocchetti CG, Van Linthout S, Volterrani M, Seferovic P, Rosano G, Coats AJS, Bayes-Genis A. Núñez J, et al. Eur J Heart Fail. 2022 Oct;24(10):1751-1766. doi: 10.1002/ejhf.2664. Epub 2022 Sep 7. Eur J Heart Fail. 2022. PMID: 36039656 Free article. Review.
This discussion focused on the clinical utility of the natriuretic peptides, carbohydrate antigen 125 (also called mucin 16), bio-adrenomedullin and mid-regional pro-adrenomedullin, ST2 (also known as interleukin-1 receptor-like 1), cluster of differentiation 146, troponin …
This discussion focused on the clinical utility of the natriuretic peptides, carbohydrate antigen 125 (also called mucin 16), bio-adr …
CD8+CD103+PD1+TIM3+ T cells in glioblastoma microenvironment correlate with prognosis.
Romagnoli G, D'Alessandris QG, Capone I, Tavilla A, Canini I, Lapenta C, Buccarelli M, Giordano M, Tirelli V, Sanchez M, Fragale A, Giannetti S, Di Bonaventura R, Lauretti L, Biffoni M, Ricci-Vitiani L, Pallini R, Gabriele L. Romagnoli G, et al. Immunology. 2024 Feb;171(2):198-211. doi: 10.1111/imm.13710. Epub 2023 Oct 26. Immunology. 2024. PMID: 37884280
Levels of Trm expressing programmed cell death protein 1 (PD1) and T cell immunoglobulin and mucin domain-containing protein 3 (TIM3) were found to be linked to clinical outcome. ...
Levels of Trm expressing programmed cell death protein 1 (PD1) and T cell immunoglobulin and mucin domain-containing protein 3 (TIM3) …
Coordinated release of nucleotides and mucin from human airway epithelial Calu-3 cells.
Kreda SM, Okada SF, van Heusden CA, O'Neal W, Gabriel S, Abdullah L, Davis CW, Boucher RC, Lazarowski ER. Kreda SM, et al. J Physiol. 2007 Oct 1;584(Pt 1):245-59. doi: 10.1113/jphysiol.2007.139840. Epub 2007 Jul 26. J Physiol. 2007. PMID: 17656429 Free PMC article.
Effective mucin dispersion into ASL requires salt and water secretion onto the mucosal surface, but how mucin secretion rate is coordinated with ion and, ultimately, water transport rates is poorly understood. ...In SPOC1 cells, an airway goblet cell model, purinerg …
Effective mucin dispersion into ASL requires salt and water secretion onto the mucosal surface, but how mucin secretion rate i …
Mucin gene (MUC1) transfected dendritic cells as vaccine: results of a phase I/II clinical trial.
Pecher G, Häring A, Kaiser L, Thiel E. Pecher G, et al. Cancer Immunol Immunother. 2002 Dec;51(11-12):669-73. doi: 10.1007/s00262-002-0317-z. Epub 2002 Oct 19. Cancer Immunol Immunother. 2002. PMID: 12439613 Free PMC article. Clinical Trial.
We performed a phase I/II clinical trial using human autologous DC transfected with cDNA of the human tumor antigen mucin (MUC1) as a vaccine in 10 patients with advanced breast, pancreatic or papillary cancer. ...After vaccination, 4 patients showed a 2- to 10-fold increa …
We performed a phase I/II clinical trial using human autologous DC transfected with cDNA of the human tumor antigen mucin (MUC1) as a …
Development and Validation of a Mass Spectrometry-Based Assay for the Molecular Diagnosis of Mucin-1 Kidney Disease.
Blumenstiel B, DeFelice M, Birsoy O, Bleyer AJ, Kmoch S, Carter TA, Gnirke A, Kidd K, Rehm HL, Ronco L, Lander ES, Gabriel S, Lennon NJ. Blumenstiel B, et al. J Mol Diagn. 2016 Jul;18(4):566-71. doi: 10.1016/j.jmoldx.2016.03.003. Epub 2016 May 5. J Mol Diagn. 2016. PMID: 27157321 Free article.
Because of variable age of disease onset and often subtle signs and symptoms, clinical diagnosis of mucin-1 kidney disease and differentiation from other forms of hereditary kidney disease have been difficult. ...Validation results indicate an accurate and reliable test fo …
Because of variable age of disease onset and often subtle signs and symptoms, clinical diagnosis of mucin-1 kidney disease and differ …
Outcomes of patients with invasive mucinous and tubular carcinomas of the breast.
Huang K, Misra S, Bagaria SP, Gabriel EM. Huang K, et al. Breast J. 2021 Sep;27(9):691-699. doi: 10.1111/tbj.14268. Epub 2021 Jun 25. Breast J. 2021. PMID: 34173285
Invasive tubular carcinoma (ITC) and invasive mucinous carcinoma (IMC) of the breast are rare histologic subtypes of breast cancer associated with favorable prognoses. ...
Invasive tubular carcinoma (ITC) and invasive mucinous carcinoma (IMC) of the breast are rare histologic subtypes of breast cancer as …
Pancreatic Cystic Lesions and Malignancy: Assessment, Guidelines, and the Field Defect.
Miller FH, Lopes Vendrami C, Recht HS, Wood CG, Mittal P, Keswani RN, Gabriel H, Borhani AA, Nikolaidis P, Hammond NA. Miller FH, et al. Radiographics. 2022 Jan-Feb;42(1):87-105. doi: 10.1148/rg.210056. Epub 2021 Dec 2. Radiographics. 2022. PMID: 34855543
The smaller cystic lesions, often branch-duct intraductal papillary mucinous neoplasms, have overlapping imaging characteristics that make diagnostic assessment of the natural history and malignancy risk confusing. ...
The smaller cystic lesions, often branch-duct intraductal papillary mucinous neoplasms, have overlapping imaging characteristics that …
Incidental diagnosis of a low-grade mucinous appendicular neoplasm: A case report.
Guzmán GA, Montealegre I, Obando AM. Guzmán GA, et al. Int J Surg Case Rep. 2021 Jun;83:105998. doi: 10.1016/j.ijscr.2021.105998. Epub 2021 May 24. Int J Surg Case Rep. 2021. PMID: 34052715 Free PMC article.
INTRODUCTION AND IMPORTANCE: Low-Grade Appendiceal Mucinous Neoplasms (LAMN) are noninvasive epithelial tumors of the appendix. ...
INTRODUCTION AND IMPORTANCE: Low-Grade Appendiceal Mucinous Neoplasms (LAMN) are noninvasive epithelial tumors of the appendix. ...
International external validation of a stratification tool to identify branch-duct intraductal papillary mucinous neoplasms at lowest risk of progression.
Overbeek KA, van Leeuwen N, Tacelli M, Anwar MS, Yousaf MN, Chhoda A, Arcidiacono PG, Gonda TA, Wallace MB, Capurso G, Farrell JJ, Cahen DL, Bruno MJ. Overbeek KA, et al. United European Gastroenterol J. 2022 Mar;10(2):169-178. doi: 10.1002/ueg2.12207. Epub 2022 Feb 24. United European Gastroenterol J. 2022. PMID: 35199484 Free PMC article.
BACKGROUND: Identifying branch-duct intraductal papillary mucinous neoplasms (BD-IPMNs) at lowest risk of progression may allow for a reduced intensity of surveillance. ...
BACKGROUND: Identifying branch-duct intraductal papillary mucinous neoplasms (BD-IPMNs) at lowest risk of progression may allow for a …
41 results